Pancreasbetegségekhez társuló cardiovascularis eltérések.

Translated title of the contribution: Cardiovascular complications of pancreatis diseases

Research output: Contribution to journalArticle

Abstract

Under physiological conditions, the pancreas scarcely influences the function of the cardiovascular system, although the hormones produced in the healthy pancreas (insulin, glucagon and somatostatin) affect the myocardial contractility in pharmacological doses. Among the diseases of the pancreas, the pancreatic tumours (insulinoma, glucagonoma and vipoma), furthermore the acute and chronic pancreatitis involve cardiovascular complications, which influence the outcome of the disease. Although the clinical picture is dominated by the metabolic changes of the excessively produced hormones in pancreatic tumours, the cardiac and vascular effects of the hormones may be considerable. In acute necrotizing pancreatitis, enzymes released from the pancreas and inflammatory mediators transform acute necrotizing pancreatitis into "multiple organ disease"; one of the important forms of this disease is the cardiovascular shock syndrome. One of the best-known complications of chronic pancreatitis is the pancreoprive diabetes mellitus, and beside that other, nonspecific cardiac alterations (e.g. ECG-changes) may occur.

Original languageHungarian
Pages (from-to)1897-1901
Number of pages5
JournalOrvosi Hetilap
Volume138
Issue number30
Publication statusPublished - Jul 27 1997

Fingerprint

Pancreas
Acute Necrotizing Pancreatitis
Chronic Pancreatitis
Vipoma
Glucagonoma
Pancreatic Hormones
Hormones
Pancreatic Diseases
Insulinoma
Heart Neoplasms
Cardiovascular System
Somatostatin
Glucagon
Blood Vessels
Shock
Diabetes Mellitus
Electrocardiography
Cardiovascular Diseases
Pharmacology
Insulin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pancreasbetegségekhez társuló cardiovascularis eltérések. / Gyöngyösi, M.; Takács, T.; Jambrik, Z.; Boda, K.; Czakó, L.; Csanády, M.

In: Orvosi Hetilap, Vol. 138, No. 30, 27.07.1997, p. 1897-1901.

Research output: Contribution to journalArticle

@article{7de4ec70e5bf4ad79353d204a64bd7a5,
title = "Pancreasbetegs{\'e}gekhez t{\'a}rsul{\'o} cardiovascularis elt{\'e}r{\'e}sek.",
abstract = "Under physiological conditions, the pancreas scarcely influences the function of the cardiovascular system, although the hormones produced in the healthy pancreas (insulin, glucagon and somatostatin) affect the myocardial contractility in pharmacological doses. Among the diseases of the pancreas, the pancreatic tumours (insulinoma, glucagonoma and vipoma), furthermore the acute and chronic pancreatitis involve cardiovascular complications, which influence the outcome of the disease. Although the clinical picture is dominated by the metabolic changes of the excessively produced hormones in pancreatic tumours, the cardiac and vascular effects of the hormones may be considerable. In acute necrotizing pancreatitis, enzymes released from the pancreas and inflammatory mediators transform acute necrotizing pancreatitis into {"}multiple organ disease{"}; one of the important forms of this disease is the cardiovascular shock syndrome. One of the best-known complications of chronic pancreatitis is the pancreoprive diabetes mellitus, and beside that other, nonspecific cardiac alterations (e.g. ECG-changes) may occur.",
author = "M. Gy{\"o}ngy{\"o}si and T. Tak{\'a}cs and Z. Jambrik and K. Boda and L. Czak{\'o} and M. Csan{\'a}dy",
year = "1997",
month = "7",
day = "27",
language = "Hungarian",
volume = "138",
pages = "1897--1901",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "30",

}

TY - JOUR

T1 - Pancreasbetegségekhez társuló cardiovascularis eltérések.

AU - Gyöngyösi, M.

AU - Takács, T.

AU - Jambrik, Z.

AU - Boda, K.

AU - Czakó, L.

AU - Csanády, M.

PY - 1997/7/27

Y1 - 1997/7/27

N2 - Under physiological conditions, the pancreas scarcely influences the function of the cardiovascular system, although the hormones produced in the healthy pancreas (insulin, glucagon and somatostatin) affect the myocardial contractility in pharmacological doses. Among the diseases of the pancreas, the pancreatic tumours (insulinoma, glucagonoma and vipoma), furthermore the acute and chronic pancreatitis involve cardiovascular complications, which influence the outcome of the disease. Although the clinical picture is dominated by the metabolic changes of the excessively produced hormones in pancreatic tumours, the cardiac and vascular effects of the hormones may be considerable. In acute necrotizing pancreatitis, enzymes released from the pancreas and inflammatory mediators transform acute necrotizing pancreatitis into "multiple organ disease"; one of the important forms of this disease is the cardiovascular shock syndrome. One of the best-known complications of chronic pancreatitis is the pancreoprive diabetes mellitus, and beside that other, nonspecific cardiac alterations (e.g. ECG-changes) may occur.

AB - Under physiological conditions, the pancreas scarcely influences the function of the cardiovascular system, although the hormones produced in the healthy pancreas (insulin, glucagon and somatostatin) affect the myocardial contractility in pharmacological doses. Among the diseases of the pancreas, the pancreatic tumours (insulinoma, glucagonoma and vipoma), furthermore the acute and chronic pancreatitis involve cardiovascular complications, which influence the outcome of the disease. Although the clinical picture is dominated by the metabolic changes of the excessively produced hormones in pancreatic tumours, the cardiac and vascular effects of the hormones may be considerable. In acute necrotizing pancreatitis, enzymes released from the pancreas and inflammatory mediators transform acute necrotizing pancreatitis into "multiple organ disease"; one of the important forms of this disease is the cardiovascular shock syndrome. One of the best-known complications of chronic pancreatitis is the pancreoprive diabetes mellitus, and beside that other, nonspecific cardiac alterations (e.g. ECG-changes) may occur.

UR - http://www.scopus.com/inward/record.url?scp=0031587996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031587996&partnerID=8YFLogxK

M3 - Article

VL - 138

SP - 1897

EP - 1901

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 30

ER -